AstraZeneca, Merck face potential class action over heartburn drugs
Class Actions 2024-07-29 2:57 pm By Cindy Cameronne
Please login to bookmark Close

A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au